Rapid and unbiased in vivo screen for lead compounds that rescue STXBP1 dysfunction and subsequent in vitro validation in human neurons

Awardee: Matthijs Verhage

Institution: Rapid and unbiased in vivo screen for lead compounds that rescue STXBP1 dysfunction and subsequent in vitro validation in human neurons

Grant Amount: $69,588

Previous
Previous

Dimethylspermine (Me2Spm) as a novel treatment approach to restore normal spermidine/spermine ratios in Snyder-Robinson Syndrome (SRS) models

Next
Next

Phenylbutyrate for STXBP1 Encephalopathy – A Pilot Study